Hiroshi Tada

11.9k total citations · 2 hit papers
157 papers, 6.9k citations indexed

About

Hiroshi Tada is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hiroshi Tada has authored 157 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 30 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Hiroshi Tada's work include Fatigue and fracture mechanics (16 papers), Breast Cancer Treatment Studies (12 papers) and HER2/EGFR in Cancer Research (12 papers). Hiroshi Tada is often cited by papers focused on Fatigue and fracture mechanics (16 papers), Breast Cancer Treatment Studies (12 papers) and HER2/EGFR in Cancer Research (12 papers). Hiroshi Tada collaborates with scholars based in Japan, United States and South Korea. Hiroshi Tada's co-authors include Paul C. Paris, G. R. Irwin, Noriaki Ohuchi, Takanori Ishida, Hideo Higuchi, Morio Ikehara, Minoru Miyashita, Hironobu Sasano, Gou Watanabe and Akihiko Suzuki and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Hiroshi Tada

147 papers receiving 6.6k citations

Hit Papers

The stress analysis of cracks handbook 2000 2026 2008 2017 2000 2000 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The stress analysis of cracks handbook
    2000 3.3k citations Hiroshi Tada et al. profile →
  2. The Stress Analysis of Cracks Handbook, Third Edition
    2000 1.0k citations Hiroshi Tada et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Tada Japan 27 3.4k 1.6k 1.5k 995 630 157 6.9k
Eric Brown United States 33 1.3k 0.4× 1.3k 0.8× 858 0.6× 2.3k 2.3× 1.0k 1.6× 99 10.5k
Brian J. Moran United States 47 6.1k 1.8× 2.1k 1.3× 1.7k 1.1× 1.3k 1.3× 222 0.4× 186 9.4k
David Taylor Ireland 60 5.8k 1.7× 3.8k 2.3× 1.5k 1.0× 1.8k 1.8× 863 1.4× 359 12.7k
Ling Zhou China 40 2.0k 0.6× 2.4k 1.5× 831 0.5× 340 0.3× 756 1.2× 361 6.0k
Shengping Shen China 40 3.0k 0.9× 1.4k 0.9× 1.3k 0.8× 3.6k 3.6× 381 0.6× 251 6.2k
Ajit Mal United States 38 3.2k 0.9× 1.2k 0.7× 1.5k 1.0× 881 0.9× 394 0.6× 173 7.1k
Chun‐Gon Kim South Korea 49 2.9k 0.8× 1.8k 1.1× 1.9k 1.3× 1.4k 1.4× 112 0.2× 334 8.3k
Johannes Schneider Germany 36 1.0k 0.3× 1.5k 0.9× 287 0.2× 638 0.6× 538 0.9× 213 5.2k
Kenneth L. Johnson United States 34 4.3k 1.3× 2.6k 1.6× 585 0.4× 982 1.0× 1.1k 1.8× 115 10.2k
Martine Wevers Belgium 52 2.2k 0.6× 1.8k 1.1× 1.1k 0.7× 975 1.0× 328 0.5× 319 8.1k

Countries citing papers authored by Hiroshi Tada

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tada more than expected).

Fields of papers citing papers by Hiroshi Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tada. The network helps show where Hiroshi Tada may publish in the future.

Co-authorship network of co-authors of Hiroshi Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tada. A scholar is included among the top collaborators of Hiroshi Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tada. Hiroshi Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yuechen, Narumi Harada‐Shoji, Narufumi Kitamura, et al.. (2024). Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer. Cancer Medicine. 13(2). e6987–e6987. 5 indexed citations
3.
Koseki, Yoshitaka, Sanjay Kumar, Hirotaka Nakatsuji, et al.. (2024). Carrier-free nano-prodrugs for minimally invasive cancer therapy. Nanoscale. 16(32). 15256–15264. 4 indexed citations
4.
Takagi, Kiyoshi, M. Yamaguchi, Ai Sato, et al.. (2024). Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance. Cancers. 16(21). 3600–3600. 4 indexed citations
5.
Nakagawa, Saki, Minoru Miyashita, Ichiro Maeda, et al.. (2024). Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Breast Cancer Research and Treatment. 204(3). 453–463. 2 indexed citations
6.
7.
Tada, Hiroshi, et al.. (2023). 497P Metastatic potential of the somatic alteration associated with TCA-cycle in breast cancer. Annals of Oncology. 34. S389–S390. 1 indexed citations
8.
Tada, Hiroshi, Kohsuke Gonda, Narufumi Kitamura, & Takanori Ishida. (2023). Clinical Significance of ABCG2/BCRP Quantified by Fluorescent Nanoparticles in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Cancers. 15(8). 2365–2365. 9 indexed citations
9.
Tada, Hiroshi, Jun Yasuda, Hidekazu Shirota, et al.. (2023). Actionability of comprehensive genomic profiling compared to the tissue-based and plasma-based assay in patients with metastatic breast cancer: A real-world study.. Journal of Clinical Oncology. 41(16_suppl). 1101–1101. 1 indexed citations
10.
Harada‐Shoji, Narumi, Akiko Ebata, Tomoyoshi Soga, et al.. (2021). Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer. Cancers. 13(17). 4375–4375. 22 indexed citations
11.
Ae, Ryusuke, Yosikazu Nakamura, Hiroshi Tada, et al.. (2018). An 18-Year Follow-up Survey of Dioxin Levels in Human Milk in Japan. Journal of Epidemiology. 28(6). 300–306. 13 indexed citations
12.
Kitamura, Narufumi, Takahiro Oikawa, Mineto Ohta, et al.. (2018). Quantitative analyses of amount and localization of radiosensitizer gold nanoparticles interacting with cancer cells to optimize radiation therapy. Biochemical and Biophysical Research Communications. 508(4). 1093–1100. 10 indexed citations
13.
Sato, Chiho, Atsushi Sekiguchi, Masaaki Kawai, et al.. (2015). Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer. PLoS ONE. 10(11). e0140655–e0140655. 29 indexed citations
14.
Miyashita, Minoru, Takanori Ishida, Akihiko Suzuki, et al.. (2014). Prognostic significance of the progesterone receptor status in Ki67-high and -low Luminal B-like HER2-negative breast cancers. Breast Cancer. 23(2). 310–317. 14 indexed citations
15.
Tada, Hiroshi, et al.. (2011). Malignant Lymphoma in Rheumatoid Arthritis Patients Treated with Methotrexate and Human Monoclonal Antibody-A Report of 2 Cases-. Orthopedics & Traumatology. 60(3). 467–472. 1 indexed citations
16.
Suzuki, Tomohiko, K. Yamamoto, Hiroshi Tada, & Kouji Uda. (2011). Cold-adapted Features of Arginine Kinase from the Deep-sea Clam Calyptogena kaikoi. Marine Biotechnology. 14(3). 294–303. 13 indexed citations
17.
Tada, Hiroshi, et al.. (1994). A Study of the LC Resonant Circuit Security Tags (Special Section of Letters Selected from the 1994 IEICE Spring Conference). IEICE Transactions on Fundamentals of Electronics Communications and Computer Sciences. 77(11). 1951–1953.
18.
Tada, Hiroshi, et al.. (1991). Clinical Effects of Allopurinol on Intractable Epilepsy. Epilepsia. 32(2). 279–283. 36 indexed citations
19.
Tada, Hiroshi, et al.. (1977). . The Nishinihon Journal of Dermatology. 39(1). 60–65. 1 indexed citations
20.
Tada, Hiroshi & Hikotaro Yoshida. (1977). Inhibition of Lysosomal Enzymes by Cepharanthin. The Nishinihon Journal of Dermatology. 39(1). 60–65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Brown Breakdown of academic impact, for papers by Brian J. Moran Breakdown of academic impact, for papers by David Taylor Breakdown of academic impact, for papers by Ling Zhou Breakdown of academic impact, for papers by Shengping Shen Breakdown of academic impact, for papers by Ajit Mal Breakdown of academic impact, for papers by Chun‐Gon Kim Breakdown of academic impact, for papers by Johannes Schneider Breakdown of academic impact, for papers by Kenneth L. Johnson Breakdown of academic impact, for papers by Martine Wevers
Rankless by CCL
2026